Home » Stocks » West Pharmaceutical Services

West Pharmaceutical Services, Inc. (WST)

Stock Price: $274.44 USD -4.20 (-1.51%)
Updated Aug 4, 2020 4:03 PM EDT - Market closed
After-hours: $275.00 +0.56 (0.20%) Aug 4, 7:59 PM

Stock Price Chart

Key Info

Market Cap 20.26B
Revenue (ttm) 1.95B
Net Income (ttm) 285.70M
Shares Out 73.84M
EPS (ttm) 3.79
PE Ratio 72.41
Forward PE 70.92
Dividend $0.64
Dividend Yield 0.23%

Stock Quote

Trading Day Aug 4, 2020
Last Price $274.44
Previous Close $278.64
Change ($) -4.20
Change (%) -1.51%
Day's Open 276.49
Day's Range 272.34 - 277.16
Day's Volume 515,422
52-Week Range 124.53 - 279.54

More Stats

Market Cap 20.26B
Enterprise Value 20.15B
Earnings Date (est) Oct 22, 2020
Ex-Dividend Date Apr 21, 2020
Shares Outstanding 73.84M
Float 73.28M
EPS (basic) 3.88
EPS (diluted) 3.79
FCF / Share 3.81
Dividend $0.64
Dividend Yield 0.23%
Earnings Yield 1.38%
FCF Yield 1.39%
Payout Ratio 16.20%
Shares Short 768,668
Short Ratio 1.17
Short % of Float 1.33%
Beta 1.12
PE Ratio 72.41
Forward PE 70.92
P/FCF Ratio 72.07
PS Ratio 10.42
PB Ratio 12.36
Revenue 1.95B
Operating Income 331.00M
Net Income 285.70M
Free Cash Flow 281.20M
Net Cash 119.00M
Net Cash / Share 1.61
Gross Margin 31.13%
Operating Margin 17.01%
Profit Margin 14.70%
FCF Margin 14.45%
ROA 9.34%
ROE 18.73%
ROIC 20.60%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (5)

Buy 3
Overweight 0
Hold 1
Underweight 0
Sell 1

Analyst Consensus: Overweight

Price Target

$265.00*
(-3.44% downside)
Low
240
Current: $274.44
High
310
Target: 265.00
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue1,8401,7171,5991,5091,4001,4211,3681,2661,1921,105
Revenue Growth7.13%7.4%5.96%7.81%-1.52%3.87%8.05%6.21%7.93%-
Gross Profit606545513501456448435388339318
Operating Income29424222819512918216213611090.70
Net Income24220715114495.6012711280.7075.5065.30
Shares Outstanding74.0073.9073.9073.3072.0070.9069.6068.1067.3066.60
Earnings Per Share3.212.741.991.911.301.751.571.151.080.95
EPS Growth17.15%37.69%4.19%46.92%-25.71%11.46%36.52%6.48%14.29%-
Dividend Per Share0.610.570.530.490.450.410.390.370.350.33
Dividend Growth7.02%7.55%8.16%8.89%9.76%6.49%5.48%5.8%6.15%-
Operating Cash Flow367289263219212183221187131138
Capital Expenditures-126-105-131-170-132-112-152-131-95.40-71.10
Free Cash Flow24118413349.2080.8071.0068.6056.1035.3067.20
Cash & Equivalents439337236203275255230174118110
Total Debt329196197229298336374412349358
Net Cash / Debt11014138.90-25.60-23.60-80.20-144-237-231-248
Assets2,3411,9791,8631,7171,6951,6701,6721,5641,3991,294
Liabilities768583583599671713765835744669
Book Value1,5731,3961,2801,1181,024957906729655626
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name West Pharmaceutical Services, Inc.
Country United States
Employees 8,200
CEO Eric Mark Green

Stock Information

Ticker Symbol WST
Stock Exchange New York Stock Exchange
Sector Healthcare
Industry Medical Instruments & Supplies
Unique Identifier NYSE: WST

Description

West Pharmaceutical Services, Inc. manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, Ireland, France, Other European countries, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, and washing and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment serves pharmaceutical, diagnostic, and medical device companies. It distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. The company was founded in 1923 and is headquartered in Exton, Pennsylvania.